RUBELLA VIRUS - ANVISA Registration 10269360464

Access comprehensive regulatory information for RUBELLA VIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10269360464 and manufactured by QUIBASA QUÍMICA BÁSICA LTDA. The registration is held by QUIBASA - QUIMICA BASICA LTDA with validity until Jun 09, 2035.

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, ABBOTT IRELAND DIAGNOSTIC DIVISION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10269360464
Registration Details
ANVISA Registration Number: 10269360464
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

BIOLISA RUBÉOLA IgG
Risk Class III

Registration Details

10269360464

25351016581202517

19400787000107

Company Information

Brazil
PT: BRASIL

Dates and Status

Jun 09, 2025

09/06/2035

09/18/2025 19:00:01